Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
22,765,909
-
Share change
-
-151,151
-
Total reported value
-
$1,949,890,985
-
Put/Call ratio
-
46%
-
Price per share
-
$85.65
-
Number of holders
-
201
-
Value change
-
-$18,461,450
-
Number of buys
-
113
-
Number of sells
-
103
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q3 2015
As of 30 Sep 2015 LIGAND PHARMACEUTICALS INC - Common Stock (LGND) had 201 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 22,765,909 shares of stock of the company.
Largest 10 holders included RS INVESTMENT MANAGEMENT CO LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, Knott David M, FMR LLC, OAK RIDGE INVESTMENTS LLC, Invesco Ltd., CARDINAL CAPITAL MANAGEMENT LLC /CT, and Bank of New York Mellon Corp.
This table shows 201 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.